Thermo Fisher receives AIFA’s GMP approval for manufacturing facility of RNA-based products in Italy
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Subscribe To Our Newsletter & Stay Updated